北米セルライト治療市場予測 2023-2032NORTH AMERICA CELLULITE TREATMENT MARKET FORECAST 2023-2032 主な調査結果 北米のセルライト治療市場は、2023年から2032年の予測期間中にCAGR 9.54%で発展すると推定されます。この地域の市場成長は、相当数の整形外科医が存在すること、老舗の市場プレイヤーの存在、これ... もっと見る
サマリー主な調査結果北米のセルライト治療市場は、2023年から2032年の予測期間中にCAGR 9.54%で発展すると推定されます。この地域の市場成長は、相当数の整形外科医が存在すること、老舗の市場プレイヤーの存在、これらの企業による戦略的イニシアティブによって促進されます。 市場インサイト 北米のセルライト治療市場の成長分析は、カナダと米国の詳細な評価を構成しています。カナダでは、肥満症例が多いことから、同国におけるセルライト治療の需要を促進することが期待されています。さらに、カナダ統計局によると、2018年には同国の成人の26%以上が肥満であったとされています。この数値は、主に不健康な食習慣や運動不足によって上昇すると予想されるため、市場の成長をさらに促進することになります。 一方、肥満は年齢とともに増加するため、カナダの老人人口の急増は、セルライト治療製品のニーズを煽ると予想されます。従って、カナダ政府の発表によると、2019年には約660万人の高齢者がおり、2040年には老人人口が全人口の4分の1近くに達するとされています。したがって、上記の要因は、推定期間中に北米のセルライト治療市場の成長を後押しすると考えられています。 競合他社の洞察 市場で事業を展開している主要企業には、AbbVie Inc、Cutera Inc、Johnson & Johnsonなどがあります。 当社のレポート提供内容は以下の通りです: - 市場全体の主要な調査結果を探る - 市場ダイナミクス(推進要因、抑制要因、機会、課題)の戦略的な内訳説明 - すべてのセグメント、サブセグメント、地域の3年間の過去データとともに、最低9年間の市場予測 - 市場セグメンテーション:主要なセグメントを徹底的に評価し、その市場規模を推定します。 - 地域別分析:地域および国別セグメントの評価とその市場占有率 - 主要な分析ポーターのファイブフォース分析、ベンダーランドスケープ、オポチュニティマトリックス、主要な購買基準など。 - 競合環境は、主要企業を要因や市場シェアなどに基づいて理論的に説明するものです。 - 企業プロファイリング:詳細な会社概要、提供する製品/サービス、SCOT分析、最近の戦略的展開など。 目次TABLE OF CONTENTS1. RESEARCH SCOPE & METHODOLOGY 1.1. STUDY OBJECTIVES 1.2. METHODOLOGY 1.3. ASSUMPTIONS & LIMITATIONS 2. EXECUTIVE SUMMARY 2.1. MARKET SIZE & ESTIMATES 2.2. MARKET OVERVIEW 2.3. SCOPE OF STUDY 2.4. CRISIS SCENARIO ANALYSIS 2.5. MAJOR MARKET FINDINGS 2.5.1. RISING BEAUTY CONSCIOUSNESS 2.5.2. GROWING PREFERENCE TOWARDS NON-INVASIVE PROCEDURES 2.5.3. RAPID TECHNOLOGICAL ADVANCEMENTS TO PROMOTE MARKET GROWTH 2.5.4. RAPIDLY CHANGING LIFESTYLES LEADING TO OBESITY 3. MARKET DYNAMICS 3.1. KEY DRIVERS 3.1.1. GROWING DEMAND FOR AESTHETIC AND COSMETIC PROCEDURES 3.1.2. RISING CASES OF OBESITY 3.1.3. RAPIDLY BOOMING MEDICAL TOURISM INDUSTRY 3.2. KEY RESTRAINTS 3.2.1. HIGH COST OF ADVANCED CELLULITE TREATMENT 3.2.2. SIDE EFFECTS POST-TREATMENT 3.2.3. LACK OF AWARENESS 4. KEY ANALYTICS 4.1. PARENT MARKET ANALYSIS 4.2. KEY TECHNOLOGY TRENDS 4.3. PORTER’S FIVE FORCES ANALYSIS 4.3.1. BUYERS POWER 4.3.2. SUPPLIERS POWER 4.3.3. SUBSTITUTION 4.3.4. NEW ENTRANTS 4.3.5. INDUSTRY RIVALRY 4.4. GROWTH PROSPECT MAPPING 4.5. MARKET MATURITY ANALYSIS 4.6. MARKET CONCENTRATION ANALYSIS 4.7. VALUE CHAIN ANALYSIS 4.7.1. RESEARCH AND DEVELOPMENT 4.7.2. PRODUCT DEVELOPMENT 4.7.3. MARKETING AND DISTRIBUTION 4.7.4. POST-SALES MONITORING 4.8. KEY BUYING CRITERIA 4.8.1. COST 4.8.2. BRAND REPUTATION 4.8.3. USABILITY 5. MARKET BY PROCEDURE 5.1. NON-INVASIVE 5.2. MINIMALLY INVASIVE 5.3. TOPICAL 6. MARKET BY TYPE 6.1. SOFT CELLULITE 6.2. HARD CELLULITE 6.3. EDEMATOUS CELLULITE 7. MARKET BY END-USER 7.1. HOSPITALS 7.2. CLINICS AND BEAUTY CENTERS 7.3. OTHER END-USERS 8. GEOGRAPHICAL ANALYSIS 8.1. NORTH AMERICA 8.1.1. MARKET SIZE & ESTIMATES 8.1.2. NORTH AMERICA CELLULITE TREATMENT MARKET DRIVERS 8.1.3. NORTH AMERICA CELLULITE TREATMENT MARKET CHALLENGES 8.1.4. NORTH AMERICA CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK 8.1.5. KEY PLAYERS IN NORTH AMERICA CELLULITE TREATMENT MARKET 8.1.6. COUNTRY ANALYSIS 8.1.6.1. UNITED STATES 8.1.6.1.1. UNITED STATES CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES 8.1.6.2. CANADA 8.1.6.2.1. CANADA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES 9. COMPETITIVE LANDSCAPE 9.1. KEY STRATEGIC DEVELOPMENTS 9.1.1. ACQUISITIONS 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS 9.1.3. PARTNERSHIPS & AGREEMENTS 9.1.4. EXPANSIONS & DIVESTITURES 9.2. COMPANY PROFILES 9.2.1. ABBVIE INC 9.2.1.1. COMPANY OVERVIEW 9.2.1.2. FINANCIAL ANALYSIS 9.2.1.3. PRODUCTS / SERVICES LIST 9.2.1.4. STRENGTHS & CHALLENGES 9.2.2. ALMA LASERS 9.2.2.1. COMPANY OVERVIEW 9.2.2.2. PRODUCTS / SERVICES LIST 9.2.3. BAUSCH HEALTH COMPANIES INC. 9.2.3.1. COMPANY OVERVIEW 9.2.3.2. FINANCIAL ANALYSIS 9.2.3.3. PRODUCTS / SERVICES LIST 9.2.3.4. STRENGTHS & CHALLENGES 9.2.4. CANDELA CORPORATION 9.2.4.1. COMPANY OVERVIEW 9.2.4.2. PRODUCTS / SERVICES LIST 9.2.4.3. STRENGTHS & CHALLENGES 9.2.5. CUTERA INC 9.2.5.1. COMPANY OVERVIEW 9.2.5.2. FINANCIAL ANALYSIS 9.2.5.3. PRODUCTS / SERVICES LIST 9.2.5.4. STRENGTHS & CHALLENGES 9.2.6. CYNOSURE LLC 9.2.6.1. COMPANY OVERVIEW 9.2.6.2. PRODUCTS / SERVICES LIST 9.2.6.3. STRENGTHS & CHALLENGES 9.2.7. ENDO INTERNATIONAL PLC 9.2.7.1. COMPANY OVERVIEW 9.2.7.2. FINANCIAL ANALYSIS 9.2.7.3. PRODUCTS / SERVICES LIST 9.2.7.4. STRENGTHS & CHALLENGES 9.2.8. GALDERMA SA 9.2.8.1. COMPANY OVERVIEW 9.2.8.2. PRODUCTS / SERVICES LIST 9.2.8.3. STRENGTHS & CHALLENGES 9.2.9. INCELER MEDIKAL CO LTD 9.2.9.1. COMPANY OVERVIEW 9.2.9.2. PRODUCTS / SERVICES LIST 9.2.9.3. STRENGTHS & CHALLENGES 9.2.10. JOHNSON & JOHNSON 9.2.10.1. COMPANY OVERVIEW 9.2.10.2. FINANCIAL ANALYSIS 9.2.10.3. PRODUCTS / SERVICES LIST 9.2.10.4. STRENGTHS & CHALLENGES 9.2.11. MERZ PHARMA GMBH & CO KGAA 9.2.11.1. COMPANY OVERVIEW 9.2.11.2. PRODUCTS / SERVICES LIST 9.2.11.3. STRENGTHS & CHALLENGES 9.2.12. NUBWAY CO LTD 9.2.12.1. COMPANY OVERVIEW 9.2.12.2. PRODUCTS / SERVICES LIST 9.2.13. SIENTRA INC 9.2.13.1. COMPANY OVERVIEW 9.2.13.2. FINANCIAL ANALYSIS 9.2.13.3. PRODUCTS / SERVICES LIST 9.2.13.4. STRENGTHS & CHALLENGES 9.2.14. SINCLAIR PHARMA 9.2.14.1. COMPANY OVERVIEW 9.2.14.2. PRODUCTS / SERVICES LIST 9.2.15. ZIMMER MEDIZINSYSTEME 9.2.15.1. COMPANY OVERVIEW 9.2.15.2. PRODUCTS / SERVICES LIST 9.2.15.3. STRENGTHS & CHALLENGES 図表リストLIST OF TABLESTABLE 1: MARKET SNAPSHOT – CELLULITE TREATMENT TABLE 2: NORTH AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) TABLE 3: NORTH AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE, FORECAST YEARS, 2023-2032 (IN $ MILLION) TABLE 4: NORTH AMERICA CELLULITE TREATMENT MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) TABLE 5: NORTH AMERICA CELLULITE TREATMENT MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION) TABLE 6: NORTH AMERICA CELLULITE TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) TABLE 7: NORTH AMERICA CELLULITE TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION) TABLE 8: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) TABLE 9: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION) TABLE 10: NORTH AMERICA CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK TABLE 11: LEADING PLAYERS OPERATING IN NORTH AMERICA CELLULITE TREATMENT MARKET TABLE 12: LIST OF ACQUISITIONS TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS TABLE 15: LIST OF EXPANSIONS & DIVESTITURES
SummaryKEY FINDINGS Table of ContentsTABLE OF CONTENTS1. RESEARCH SCOPE & METHODOLOGY 1.1. STUDY OBJECTIVES 1.2. METHODOLOGY 1.3. ASSUMPTIONS & LIMITATIONS 2. EXECUTIVE SUMMARY 2.1. MARKET SIZE & ESTIMATES 2.2. MARKET OVERVIEW 2.3. SCOPE OF STUDY 2.4. CRISIS SCENARIO ANALYSIS 2.5. MAJOR MARKET FINDINGS 2.5.1. RISING BEAUTY CONSCIOUSNESS 2.5.2. GROWING PREFERENCE TOWARDS NON-INVASIVE PROCEDURES 2.5.3. RAPID TECHNOLOGICAL ADVANCEMENTS TO PROMOTE MARKET GROWTH 2.5.4. RAPIDLY CHANGING LIFESTYLES LEADING TO OBESITY 3. MARKET DYNAMICS 3.1. KEY DRIVERS 3.1.1. GROWING DEMAND FOR AESTHETIC AND COSMETIC PROCEDURES 3.1.2. RISING CASES OF OBESITY 3.1.3. RAPIDLY BOOMING MEDICAL TOURISM INDUSTRY 3.2. KEY RESTRAINTS 3.2.1. HIGH COST OF ADVANCED CELLULITE TREATMENT 3.2.2. SIDE EFFECTS POST-TREATMENT 3.2.3. LACK OF AWARENESS 4. KEY ANALYTICS 4.1. PARENT MARKET ANALYSIS 4.2. KEY TECHNOLOGY TRENDS 4.3. PORTER’S FIVE FORCES ANALYSIS 4.3.1. BUYERS POWER 4.3.2. SUPPLIERS POWER 4.3.3. SUBSTITUTION 4.3.4. NEW ENTRANTS 4.3.5. INDUSTRY RIVALRY 4.4. GROWTH PROSPECT MAPPING 4.5. MARKET MATURITY ANALYSIS 4.6. MARKET CONCENTRATION ANALYSIS 4.7. VALUE CHAIN ANALYSIS 4.7.1. RESEARCH AND DEVELOPMENT 4.7.2. PRODUCT DEVELOPMENT 4.7.3. MARKETING AND DISTRIBUTION 4.7.4. POST-SALES MONITORING 4.8. KEY BUYING CRITERIA 4.8.1. COST 4.8.2. BRAND REPUTATION 4.8.3. USABILITY 5. MARKET BY PROCEDURE 5.1. NON-INVASIVE 5.2. MINIMALLY INVASIVE 5.3. TOPICAL 6. MARKET BY TYPE 6.1. SOFT CELLULITE 6.2. HARD CELLULITE 6.3. EDEMATOUS CELLULITE 7. MARKET BY END-USER 7.1. HOSPITALS 7.2. CLINICS AND BEAUTY CENTERS 7.3. OTHER END-USERS 8. GEOGRAPHICAL ANALYSIS 8.1. NORTH AMERICA 8.1.1. MARKET SIZE & ESTIMATES 8.1.2. NORTH AMERICA CELLULITE TREATMENT MARKET DRIVERS 8.1.3. NORTH AMERICA CELLULITE TREATMENT MARKET CHALLENGES 8.1.4. NORTH AMERICA CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK 8.1.5. KEY PLAYERS IN NORTH AMERICA CELLULITE TREATMENT MARKET 8.1.6. COUNTRY ANALYSIS 8.1.6.1. UNITED STATES 8.1.6.1.1. UNITED STATES CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES 8.1.6.2. CANADA 8.1.6.2.1. CANADA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES 9. COMPETITIVE LANDSCAPE 9.1. KEY STRATEGIC DEVELOPMENTS 9.1.1. ACQUISITIONS 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS 9.1.3. PARTNERSHIPS & AGREEMENTS 9.1.4. EXPANSIONS & DIVESTITURES 9.2. COMPANY PROFILES 9.2.1. ABBVIE INC 9.2.1.1. COMPANY OVERVIEW 9.2.1.2. FINANCIAL ANALYSIS 9.2.1.3. PRODUCTS / SERVICES LIST 9.2.1.4. STRENGTHS & CHALLENGES 9.2.2. ALMA LASERS 9.2.2.1. COMPANY OVERVIEW 9.2.2.2. PRODUCTS / SERVICES LIST 9.2.3. BAUSCH HEALTH COMPANIES INC. 9.2.3.1. COMPANY OVERVIEW 9.2.3.2. FINANCIAL ANALYSIS 9.2.3.3. PRODUCTS / SERVICES LIST 9.2.3.4. STRENGTHS & CHALLENGES 9.2.4. CANDELA CORPORATION 9.2.4.1. COMPANY OVERVIEW 9.2.4.2. PRODUCTS / SERVICES LIST 9.2.4.3. STRENGTHS & CHALLENGES 9.2.5. CUTERA INC 9.2.5.1. COMPANY OVERVIEW 9.2.5.2. FINANCIAL ANALYSIS 9.2.5.3. PRODUCTS / SERVICES LIST 9.2.5.4. STRENGTHS & CHALLENGES 9.2.6. CYNOSURE LLC 9.2.6.1. COMPANY OVERVIEW 9.2.6.2. PRODUCTS / SERVICES LIST 9.2.6.3. STRENGTHS & CHALLENGES 9.2.7. ENDO INTERNATIONAL PLC 9.2.7.1. COMPANY OVERVIEW 9.2.7.2. FINANCIAL ANALYSIS 9.2.7.3. PRODUCTS / SERVICES LIST 9.2.7.4. STRENGTHS & CHALLENGES 9.2.8. GALDERMA SA 9.2.8.1. COMPANY OVERVIEW 9.2.8.2. PRODUCTS / SERVICES LIST 9.2.8.3. STRENGTHS & CHALLENGES 9.2.9. INCELER MEDIKAL CO LTD 9.2.9.1. COMPANY OVERVIEW 9.2.9.2. PRODUCTS / SERVICES LIST 9.2.9.3. STRENGTHS & CHALLENGES 9.2.10. JOHNSON & JOHNSON 9.2.10.1. COMPANY OVERVIEW 9.2.10.2. FINANCIAL ANALYSIS 9.2.10.3. PRODUCTS / SERVICES LIST 9.2.10.4. STRENGTHS & CHALLENGES 9.2.11. MERZ PHARMA GMBH & CO KGAA 9.2.11.1. COMPANY OVERVIEW 9.2.11.2. PRODUCTS / SERVICES LIST 9.2.11.3. STRENGTHS & CHALLENGES 9.2.12. NUBWAY CO LTD 9.2.12.1. COMPANY OVERVIEW 9.2.12.2. PRODUCTS / SERVICES LIST 9.2.13. SIENTRA INC 9.2.13.1. COMPANY OVERVIEW 9.2.13.2. FINANCIAL ANALYSIS 9.2.13.3. PRODUCTS / SERVICES LIST 9.2.13.4. STRENGTHS & CHALLENGES 9.2.14. SINCLAIR PHARMA 9.2.14.1. COMPANY OVERVIEW 9.2.14.2. PRODUCTS / SERVICES LIST 9.2.15. ZIMMER MEDIZINSYSTEME 9.2.15.1. COMPANY OVERVIEW 9.2.15.2. PRODUCTS / SERVICES LIST 9.2.15.3. STRENGTHS & CHALLENGES List of Tables/GraphsLIST OF TABLESTABLE 1: MARKET SNAPSHOT – CELLULITE TREATMENT TABLE 2: NORTH AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) TABLE 3: NORTH AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE, FORECAST YEARS, 2023-2032 (IN $ MILLION) TABLE 4: NORTH AMERICA CELLULITE TREATMENT MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) TABLE 5: NORTH AMERICA CELLULITE TREATMENT MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION) TABLE 6: NORTH AMERICA CELLULITE TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) TABLE 7: NORTH AMERICA CELLULITE TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION) TABLE 8: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION) TABLE 9: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION) TABLE 10: NORTH AMERICA CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK TABLE 11: LEADING PLAYERS OPERATING IN NORTH AMERICA CELLULITE TREATMENT MARKET TABLE 12: LIST OF ACQUISITIONS TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS TABLE 15: LIST OF EXPANSIONS & DIVESTITURES
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
Inkwood Research社の分野での最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問Inkwood Research社はどのような調査会社ですか?Inkwood Researchは世界40ヶ国以上の国を対象に広範な市場を調査し、世界市場全体を調査したレポートに加え、アジア太平洋地域、欧州、北米などの主要地域や主要国毎のレポートも数多く出版してい... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/25 10:26 155.25 円 163.23 円 198.36 円 |